BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
0 | 0.00 | 0.00 | 0 |
0 | 0.00 | 0.00 | 0 |
0 | 0.00 | 0.00 | 0 |
0 | 0.00 | 0.00 | 0 |
0 | 0.00 | 0.00 | 0 |
2393 | Total | Total | 398 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
0 | 0.00 | 0.00 | 0 |
0 | 0.00 | 0.00 | 0 |
0 | 0.00 | 0.00 | 0 |
0 | 0.00 | 0.00 | 0 |
0 | 0.00 | 0.00 | 0 |
2393 | Total | Total | 398 |
Open | 804.85 |
Previous Close | 814.25 |
Volume | 35,148.00 |
Value (Lacs) | 284.87 |
VWAP | 812.17 |
Beta | |
Mkt Cap (Rs. Cr.) | 7,471 |
High | 820.80 |
Low | 804.85 |
UC Limit | 977.10 |
LC Limit | 651.40 |
52 Week High | 1,670.95 |
52 Week Low | 513.05 |
Face Value | 10.00 |
All Time High | 1,675.00 |
All Time Low | 47.10 |
20D Avg Volume | 269,867 |
20D Avg Delivery(%) | 45.05 |
Book Value Per Share | 246.45 |
Dividend Yield | 0.49 |
TTM EPS See historical trend | 39.38 (+5,301.92% YoY) |
TTM PE See historical trend | 20.58 (Average PE) |
P/B See historical trend | 3.29 (Average P/B) |
Sector PE | 39.88 |
*Delayed by 20 seconds.
Stock Score
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
10 out of 17 years Strides Pharma Science has given negative returns in October.
Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
---|---|---|---|---|---|
October | 25.11% (2019) | 8.59% | -13.57% (2009) | -5.88% | 0.08% |
Stocks to Watch Today: Infosys, Voltamp Transformers, RailTel, Strides Pharma, IRB Infra, Brigade Enterprises, Prime Focus, Amanta Healthcare in focus on 09 September Sep 09 2025 01:49 AM
Strides Pharma Standalone June 2025 Net Sales at Rs 498.62 crore, down 10.12% Y-o-Y Jul 30 2025 10:35 AM
Strides Pharma Consolidated June 2025 Net Sales at Rs 1,119.74 crore, up 2.96% Y-o-Y Jul 29 2025 02:51 PM
Strides Pharma sets July 22 as record date for Rs 4 per share final dividend Jul 10 2025 12:34 PM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 518350 | Price 558.88 | % Traded 0.54 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Strides Pharma | 810.50 | -0.46 | 7,470.60 | 20.58 | 3.29 | 140.81 | -50.24 | 407 | 4,565 | 0.70 |
Sun Pharma | 1,690.50 | 0.11 | 405,607.58 | 39.10 | 5.87 | 15.13 | -11.51 | 10,980 | 52,578 | 0.03 |
Divis Labs | 6,587.00 | -0.26 | 174,864.15 | 75.83 | 12.75 | 14.63 | 9.38 | 2,191 | 9,360 | 0.00 |
Cipla | 1,663.60 | 1.49 | 134,379.90 | 24.92 | 4.74 | 16.90 | 7.21 | 5,291 | 27,547 | 0.00 |
Torrent Pharma | 3,590.90 | 0.57 | 121,532.37 | 60.71 | 16.19 | 25.17 | 4.10 | 1,911 | 11,516 | 0.40 |